Case number 2018-2321
Janssen Biotech, Inc. v. Celltrion Healthcare Co., Ltd > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | JANSSEN BIOTECH, INC. v. CELLTRION HEALTHCARE CO., LTD [RULE 36 JUDGMENT] [nonprecedential] (0) |
| Apr 13, 2020 | 82 | Mandate issued to the United States District Court for the District of Massachusetts. Service as of this date by the Clerk of Court. [686373] [18-2321, 18-2350] [JAB] [Entered: 04/13/2020 12:49 PM] (1) |
| Mar 5, 2020 | 81 | JUDGMENT. AFFIRMED. Issued pursuant to Federal Circuit Rule 36. Terminated on the merits after oral argument. COSTS: No Costs. Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [676475] [18-2321, 18-2350] [JAB] [Entered: 03/05/2020 10:04 AM] (2) |
| Mar 4, 2020 | 80 | Submitted after ORAL ARGUMENT by Gregory Diskant for Janssen Biotech, Inc. and James F. Hurst for Hospira, Inc., Celltrion Healthcare Co., Ltd. and Celltrion, Inc. Panel: Judge: Wallach , Judge: Taranto , Judge: Stoll. [676121] [JCP] [Entered: 03/04/2020 10:55 AM] (0) |
| Jan 28, 2020 | 79 | Response to notice of oral argument from the Cross-Appellants Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira, Inc.. [666509] [18-2321] [James Hurst] [Entered: 01/28/2020 01:24 PM] (3) |
| Jan 27, 2020 | 78 | **TEXT ONLY** ORDER granting motion to withdraw attorney Elizabeth A. Cutri [77] filed by Cross-Appellants Hospira, Inc., Celltrion Healthcare Co., Ltd. and Celltrion, Inc. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [666023] [JAB] [Entered: 01/27/2020 07:56 AM] (0) |
| Jan 24, 2020 | 77 | MOTION of Cross-Appellants Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira, Inc. to withdraw counsel Elizabeth A. Cutri [Consent: unopposed]. Service: 01/24/2020 by email. [665988] [18-2321] [William Burgess] [Entered: 01/24/2020 05:23 PM] (4) |
| Jan 24, 2020 | 76 | Response to notice of oral argument from the Appellant Janssen Biotech, Inc.. [665870] [18-2321] [Gregory Diskant] [Entered: 01/24/2020 12:48 PM] (2) |
| Jan 21, 2020 | 75 | NOTICE OF ORAL ARGUMENT. Panel: 2003I. Case scheduled March 4, 2020 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, NW Washington, DC 20439), Courtroom 203. Response to Notice of Oral Argument due: 02/14/2020. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. [664648] [JAB] [Entered: 01/21/2020 01:41 PM] (2) |
| Jan 8, 2020 | 74 | The following conflict dates submitted by Attorney Gregory Diskant for Appellant Janssen Biotech, Inc. have been accepted by the court: 05/06/2020, 05/07/2020, 07/06/2020, 07/07/2020, 07/08/2020, 07/09/2020, 07/10/2020. [661367] [JAB] [Entered: 01/08/2020 07:58 AM] (0) |
| Jan 7, 2020 | 73 | Notice from Appellant Janssen Biotech, Inc. regarding conflicts with oral argument. Service: 01/07/2020 by email. [661141] [18-2321] [Gregory Diskant] [Entered: 01/07/2020 08:52 AM] (3) |
| Jan 7, 2020 | 72 | The following conflict dates submitted by Attorney James F. Hurst for Cross-Appellants Hospira, Inc., Celltrion Healthcare Co., Ltd. and Celltrion, Inc. have been accepted by the court: 04/06/2020, 04/07/2020, 04/08/2020, 04/09/2020, 04/10/2020, 05/04/2020, 05/05/2020, 05/06/2020, 05/07/2020, 05/08/2020. [661118] [JAB] [Entered: 01/07/2020 07:54 AM] (0) |
| Dec 31, 2019 | 71 | Notice from Cross-Appellants Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira, Inc. regarding conflicts with oral argument. Service: 12/31/2019 by email. [659866] [18-2321] [James Hurst] [Entered: 12/31/2019 02:51 PM] (3) |
| Dec 2, 2019 | 70 | RESPONSE of Cross-Appellants Celltrion Healthcare Co., Ltd., Celltrion, Inc., and Hospira, Inc. to the supplemental authority [69] filed by Appellant Janssen Biotech, Inc. Service: 12/02/2019 by email. [653336] [18-2321] [James Hurst] [Entered: 12/02/2019 05:34 PM] (3) |
| Nov 15, 2019 | 69 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellant Janssen Biotech, Inc.. Service: 11/15/2019 by email. [649638] [18-2321] [Gregory Diskant] [Entered: 11/15/2019 11:34 AM] (15) |
| Oct 23, 2019 | 68 | ORDER granting motion [63] to the extent that ECF No. [44] will be treated as confidential. Service as of this date by the Clerk of Court. [644275] [NL] [Entered: 10/23/2019 05:04 PM] (2) |
| Oct 21, 2019 | 67 | 6 paper copies of the Corrected Confidential Joint Appendix Brief (Vol. I - V) [66] received from Appellant Janssen Biotech, Inc. and Cross-Appellants Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira, Inc.. [643518] [CJF] [Entered: 10/21/2019 02:39 PM] (0) |
| Oct 11, 2019 | 66 | MODIFIED ENTRY: CORRECTED CONFIDENTIAL JOINT APPENDIX FILED for Appellant Janssen Biotech, Inc. and Cross-Appellants Celltrion Healthcare Co., Ltd., Celltrion, Inc., and Hospira, Inc. Number of Pages: 2617. Service: 10/11/2019 by email. [641926]--[Edited 10/15/2019 by JAL - Compliance review complete] [Gregory Diskant] [Entered: 10/11/2019 03:48 PM] (0) |
| Oct 11, 2019 | 65 | MODIFIED ENTRY: CORRECTED JOINT APPENDIX FILED for Appellant Janssen Biotech, Inc. and Cross-Appellants Celltrion Healthcare Co., Ltd., Celltrion, Inc., and Hospira, Inc. Number of Pages: 2621. Service: 10/11/2019 by email. [641923]--[Edited 10/15/2019 by JAL - Compliance review complete] [Gregory Diskant] [Entered: 10/11/2019 03:43 PM] (2621) |
| Oct 11, 2019 | 64 | Notice of Correction to Doc No. [45], [44] for Cross-Appellants Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc. and Appellant Janssen Biotech, Inc.. Service: 10/11/2019 by email. [641921] [18-2321] [Gregory Diskant] [Entered: 10/11/2019 03:38 PM] (4) |
| Oct 9, 2019 | 63 | MOTION of Cross-Appellants Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira, Inc. to continue restriction on public access to non-confidential joint appendix (ECF#44) through and including October 11, 2019 [Consent: unopposed]. Service: 10/09/2019 by email. [641280] [18-2321] [William Burgess] [Entered: 10/09/2019 11:25 AM] (6) |
| Jul 23, 2019 | 62 | **TEXT ONLY** ORDER granting motion to withdraw Daniel A. Friedman as counsel [61] filed by Appellant Janssen Biotech, Inc. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [622959] [JAL] [Entered: 07/23/2019 04:14 PM] (0) |
| Jul 22, 2019 | 61 | MOTION of Appellant Janssen Biotech, Inc. to withdraw counsel Daniel A. Friedman [Consent: unopposed]. Service: 07/22/2019 by email. [622573] [18-2321] [Daniel Friedman] [Entered: 07/22/2019 03:10 PM] (5) |
| Jul 12, 2019 | 60 | The following conflict dates submitted by Attorney Gregory Diskant for Appellant Janssen Biotech, Inc. have been accepted by the court: 09/30/2019, 10/01/2019. [620637] [JAB] [Entered: 07/12/2019 03:36 PM] (0) |
| Jul 12, 2019 | 59 | Notice from Appellant Janssen Biotech, Inc. regarding conflicts with oral argument. Service: 07/12/2019 by email. [620610] [18-2321] [Gregory Diskant] [Entered: 07/12/2019 02:07 PM] (3) |
| Jul 12, 2019 | 58 | RESPONSE of Cross-Appellants Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira, Inc. to the supplemental authority [43] filed by Appellant Janssen Biotech, Inc. Service: 07/12/2019 by email. [620580] [18-2321] [James Hurst] [Entered: 07/12/2019 12:47 PM] (3) |
| Jul 12, 2019 | 57 | The following conflict dates submitted by Attorney James F. Hurst for Cross-Appellants Hospira, Inc., Celltrion Healthcare Co., Ltd. and Celltrion, Inc. have been accepted by the court: 09/04/2019, 09/05/2019, 09/06/2019, 12/05/2019, 12/06/2019, 01/06/2020, 01/07/2020, 01/08/2020, 01/09/2020, 01/10/2020. [620470] [JAB] [Entered: 07/12/2019 09:02 AM] (0) |
| Jul 11, 2019 | 56 | Notice from Cross-Appellants Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira, Inc. regarding conflicts with oral argument. Service: 07/11/2019 by email. [620437] [18-2321] [James Hurst] [Entered: 07/11/2019 06:10 PM] (3) |
| Jul 11, 2019 | 55 | 6 paper copies of the Confidential Joint Appendix Brief (Vol. I - V) [45] received from Appellant Janssen Biotech, Inc. and Cross-Appellants Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira, Inc.. [620287] [CJF] [Entered: 07/11/2019 11:12 AM] (0) |
| Jul 11, 2019 | 54 | 6 paper copies of the Reply Brief [35] received from Cross-Appellants Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira, Inc.. [620286] [CJF] [Entered: 07/11/2019 11:11 AM] (0) |
| Jul 11, 2019 | 53 | 6 paper copies of the Opening Response Brief [26] received from Cross-Appellants Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira, Inc.. [620285] [CJF] [Entered: 07/11/2019 11:10 AM] (0) |
| Jul 10, 2019 | 52 | 6 paper copies of the Opening Brief [20] received from Appellant Janssen Biotech, Inc.. [619983] [CJF] [Entered: 07/10/2019 10:00 AM] (0) |
| Jul 9, 2019 | 51 | 6 paper copies of the Response and Reply Brief [30] received from Appellant Janssen Biotech, Inc.. [619932] [CJF] [Entered: 07/10/2019 07:10 AM] (0) |
| Jul 9, 2019 | 50 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellant Janssen Biotech, Inc.. Service: 07/09/2019 by email. [619907] [18-2321] [Eugene Gelernter] [Entered: 07/09/2019 04:57 PM] (2) |
| Jul 8, 2019 | 49 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Cross-Appellants Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira, Inc.. Service: 07/08/2019 by email. [619578] [18-2321] [James Hurst] [Entered: 07/08/2019 03:44 PM] (3) |
| Jul 8, 2019 | 48 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [619381] [JAL] [Entered: 07/08/2019 09:03 AM] (1) |
| Jul 8, 2019 | 47 | Outstanding paper copies of all briefs and appendices must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(1). [619380] [JAL] [Entered: 07/08/2019 09:03 AM] (0) |
| Jul 8, 2019 | 46 | Notice to counsel: The record of this case indicates that the Certificate of Compliance with Fed. Cir. R. 11(d) has not been filed. IF any portion of the record in the trial court is subject to a protective order, counsel should promptly file the appropriate Certificate of Compliance using the Cert of Compliance - Protective Order event. Service as of this date by the Clerk of Court. [619378] [JAL] [Entered: 07/08/2019 08:59 AM] (0) |
| Jul 2, 2019 | 45 | MODIFIED ENTRY: CONFIDENTIAL JOINT APPENDIX FILED for Appellant Janssen Biotech, Inc. and Cross-Appellant Celltrion Healthcare Co., Ltd., Celltrion, Inc., and Hospira, Inc. Number of Pages: 2617. Service: 07/02/2019 by email. [618710]--[Edited 07/08/2019 by JAL - Compliance review complete] This document has been corrected. See Doc No.[66] [Gregory Diskant] [Entered: 07/02/2019 05:03 PM] (0) |
| Jul 2, 2019 | 44 | MODIFIED ENTRY: JOINT APPENDIX FILED for Appellant Janssen Biotech, Inc. and Cross-Appellants Celltrion Healthcare Co., Ltd., Celltrion, Inc., and Hospira, Inc. Number of Pages: 2621. Service: 07/02/2019 by email. [618708] --[Edited 07/08/2019 by JAL - Compliance review complete] This document has been corrected. See Doc No.[65] [Gregory Diskant] [Entered: 07/02/2019 04:58 PM] (0) |
| Jun 28, 2019 | 43 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellant Janssen Biotech, Inc.. Service: 06/28/2019 by email. [617841] [18-2321] [Gregory Diskant] [Entered: 06/28/2019 03:10 PM] (4) |
| Jun 25, 2019 | 42 | Joint Statement of Compliance with Fed. Cir. R. 33 for Appellant Janssen Biotech, Inc. and Cross-Appellants Celltrion Healthcare Co., Ltd. and Hospira, Inc.. Service: 06/25/2019 by email. [616826] [18-2321] [Eugene Gelernter] [Entered: 06/25/2019 03:06 PM] (3) |
| Jun 25, 2019 | 41 | **TEXT ONLY** ORDER granting motion to extend time to file appendix [40] filed by Appellant Janssen Biotech, Inc. Appendix is due 07/02/2019. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [616610] [JAL] [Entered: 06/25/2019 08:50 AM] (0) |
| Jun 24, 2019 | 40 | MOTION of Appellant Janssen Biotech, Inc. to extend the time to 07/02/2019 to file the appendix [Consent: unopposed]. Service: 06/24/2019 by email. [616551] [18-2321] [Eugene Gelernter] [Entered: 06/24/2019 06:13 PM] (11) |
| Jun 24, 2019 | 39 | **TEXT ONLY** ORDER granting motion to withdraw Irena Royzman as counsel [38] filed by Appellant Janssen Biotech, Inc. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [616347] [JAL] [Entered: 06/24/2019 12:59 PM] (0) |
| Jun 24, 2019 | 38 | MOTION of Irena Royzman Appellant Janssen Biotech, Inc. to withdraw counsel Irena Royzman [Consent: unopposed]. Service: 06/24/2019 by email. [616340] [18-2321] [Irena Royzman] [Entered: 06/24/2019 12:46 PM] (4) |
| Jun 19, 2019 | 37 | NOTICE OF NON-COMPLIANCE: The submission of Appellant Janssen Biotech, Inc., Motion to Withdraw Counsel [36], is not in compliance with the rules of this court (see attached). Compliant document is due 06/26/2019. Service as of this date by the Clerk of Court. [615573] [JAL] [Entered: 06/19/2019 02:35 PM] (2) |
| Jun 19, 2019 | 36 | MOTION of Appellant Janssen Biotech, Inc. to withdraw counsel Irena Royzman [Consent: unopposed]. Service: 06/19/2019 by email. [615503] [18-2321] This document is non-compliant. See Doc No.[37] [Irena Royzman] [Entered: 06/19/2019 11:56 AM] (1) |
| Jun 18, 2019 | 35 | MODIFIED ENTRY: REPLY BRIEF FILED for Cross-Appellants Celltrion Healthcare Co., Ltd., Celltrion, Inc., and Hospira, Inc. Number of Pages: 30. Service: 06/18/2019 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [615307] --[Edited 06/21/2019 by JAL - Compliance review complete] [James Hurst] [Entered: 06/18/2019 06:30 PM] (37) |
| Jun 18, 2019 | 34 | Amended Entry of appearance for William H. Burgess as of counsel for Cross-Appellants Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira, Inc.. Service: 06/18/2019 by email. [615305] [18-2321] [John O'Quinn] [Entered: 06/18/2019 06:23 PM] (2) |
| Jun 18, 2019 | 33 | Amended Entry of appearance for John C. O'Quinn as of counsel for Cross-Appellants Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira, Inc.. Service: 06/18/2019 by email. [615302] [18-2321] [John O'Quinn] [Entered: 06/18/2019 06:21 PM] (2) |
| May 9, 2019 | 32 | **TEXT ONLY** ORDER granting motion to extend time to file brief [31] filed by Cross-Appellants Hospira, Inc., Celltrion Healthcare Co., Ltd., and Celltrion, Inc. Cross-Appellants' reply brief is due 06/18/2019. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [606326] [JAL] [Entered: 05/09/2019 01:47 PM] (0) |
| May 8, 2019 | 31 | MOTION of Cross-Appellants Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira, Inc. to extend the time to 06/18/2019 to file the Cross-Appellants' Reply Brief. [Consent: unopposed]. Service: 05/08/2019 by email. [605823] [18-2321] [William Burgess] [Entered: 05/08/2019 12:53 PM] (9) |
| May 7, 2019 | 30 | MODIFIED ENTRY: RESPONSE AND REPLY BRIEF FILED for Appellant Janssen Biotech, Inc. Number of Pages: 65. Service: 05/07/2019 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [605683] --[Edited 05/08/2019 by JAL - Compliance review complete] [Gregory Diskant] [Entered: 05/07/2019 04:02 PM] (78) |
| Apr 26, 2019 | 29 | Entry of appearance for Daniel A. Friedman as of counsel for Appellant Janssen Biotech, Inc.. Service: 04/26/2019 by email. [603383] [18-2321] [Daniel Friedman] [Entered: 04/26/2019 03:52 PM] (2) |
| Mar 4, 2019 | 28 | **TEXT ONLY** ORDER granting motion to extend time to file brief [27] filed by Appellant Janssen Biotech, Inc. Appellant's response and reply brief is due 05/07/2019. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [590104] [JAL] [Entered: 03/04/2019 02:28 PM] (0) |
| Feb 27, 2019 | 27 | MODIFIED ENTRY: MOTION of Appellant Janssen Biotech, Inc. to extend the time to 05/07/2019 to file Response/Reply. Any response is due within 10 days of service [Consent: unopposed]. Service: 02/27/2019 by email. [589077] [18-2321] --[Edited 03/04/2019 by CAB to add correct relief] [Eugene Gelernter] [Entered: 02/27/2019 02:12 PM] (8) |
| Feb 11, 2019 | 26 | MODIFIED ENTRY: RESPONSE BRIEF FILED for Cross-Appellants Celltrion Healthcare Co., Ltd., Celltrion, Inc., and Hospira, Inc. Number of Pages: 74. Service: 02/11/2019 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [585032] --[Edited 02/13/2019 by JAL - Compliance review complete] [James Hurst] [Entered: 02/11/2019 09:00 PM] (124) |
| Feb 11, 2019 | 25 | Amended Certificate of Interest for the Cross-Appellants Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira, Inc.. Service: 02/11/2019 by email. [584930] [18-2321] [James Hurst] [Entered: 02/11/2019 03:37 PM] (3) |
| Feb 11, 2019 | 24 | Entry of appearance for John C. O'Quinn as of counsel for Cross-Appellants Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira, Inc.. Service: 02/10/2019 by email. [584647] [18-2321] [William Burgess] [Entered: 02/10/2019 12:19 PM] (2) |
| Feb 11, 2019 | 23 | Entry of appearance for William H. Burgess as of counsel for Cross-Appellants Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira, Inc.. Service: 02/10/2019 by email. [584646] [18-2321] [William Burgess] [Entered: 02/10/2019 12:16 PM] (2) |
| Dec 18, 2018 | 22 | **TEXT ONLY** ORDER granting motion to extend time to file brief [21] filed by Cross-Appellants. Cross-Appellants Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira, Inc. brief is due 02/11/2019. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [572675] [JB] [Entered: 12/18/2018 01:13 PM] (0) |
| Dec 12, 2018 | 21 | MOTION of Cross-Appellants Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira, Inc. to extend the time to 02/11/2019 to file the Cross-Appellants' Appeal Brief. [Consent: unopposed]. Service: 12/12/2018 by email. [571429] [18-2321] [Bryan Hales] [Entered: 12/12/2018 06:22 PM] (8) |
| Dec 10, 2018 | 20 | MODIFIED ENTRY: BRIEF FILED for Appellant Janssen Biotech, Inc.. Number of Pages: 65. Service: 12/10/2018 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [570588] --[Edited 12/18/2018 by JBR - compliance review complete] [Gregory Diskant] [Entered: 12/10/2018 03:51 PM] (207) |
| Nov 14, 2018 | 19 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a)and Fed. Cir. R. 47.3 to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [564857] [JB] [Entered: 11/14/2018 02:05 PM] (0) |
| Nov 8, 2018 | 18 | Entry of appearance for Andrew D. Cohen as of counsel for Appellant Janssen Biotech, Inc.. Service: 11/08/2018 by email. [563746] [18-2321] [Andrew Cohen] [Entered: 11/08/2018 06:09 PM] (2) |
| Nov 8, 2018 | 17 | Entry of appearance for Aron Fischer as of counsel for Appellant Janssen Biotech, Inc.. Service: 11/08/2018 by email. [563742] [18-2321] [Aron Fischer] [Entered: 11/08/2018 06:06 PM] (2) |
| Nov 8, 2018 | 16 | Entry of appearance for Irena Royzman as of counsel for Appellant Janssen Biotech, Inc.. Service: 11/08/2018 by email. [563738] [18-2321] [Irena Royzman] [Entered: 11/08/2018 06:02 PM] (2) |
| Sep 27, 2018 | 15 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: ERROR: motion to extend time to file brief [13] did not contain a certificate of compliance pursuant to FRAP 32(g)(1). Also, the motion did not containt the cross-appeal case number 18-2350. CORRECTION: All motions require a certificate of compliance with the word count. All documents should reflect 18-2321, 18-2350. Please ensure future motions contain these requirements. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [552942] [JB] [Entered: 09/27/2018 10:37 AM] (0) |
| Sep 27, 2018 | 14 | **TEXT ONLY** ORDER granting motion to extend time to file brief [13] filed by Appellant Janssen Biotech, Inc. Brief is due 12/10/2018. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [552939] [JB] [Entered: 09/27/2018 10:29 AM] (0) |
| Sep 25, 2018 | 13 | MOTION of Appellant Janssen Biotech, Inc. to extend the time to 12/10/2018 to file the 40-day extension. [Consent: unopposed]. Service: 09/25/2018 by clerk. [552563] [18-2321] [Eugene Gelernter] [Entered: 09/25/2018 06:13 PM] (9) |
| Sep 13, 2018 | 12 | Docketing Statement for the Cross-Appellants Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira, Inc.. Service: 09/13/2018 by email. [549489] [18-2321] [James Hurst] [Entered: 09/13/2018 12:26 PM] (3) |
| Sep 13, 2018 | 11 | Certificate of Interest for the Cross-Appellants Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira, Inc.. Service: 09/13/2018 by email. [549487] [18-2321] [James Hurst] [Entered: 09/13/2018 12:21 PM] (3) |
| Sep 13, 2018 | 10 | Entry of appearance for Elizabeth Cutri as of counsel for Cross-Appellants Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira, Inc.. Service: 09/13/2018 by email. [549485] [18-2321] [James Hurst] [Entered: 09/13/2018 12:19 PM] (2) |
| Sep 13, 2018 | 9 | Entry of appearance for Bryan S. Hales as of counsel for Cross-Appellants Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira, Inc.. Service: 09/13/2018 by email. [549483] [18-2321] [James Hurst] [Entered: 09/13/2018 12:17 PM] (2) |
| Sep 13, 2018 | 8 | Entry of appearance for James F. Hurst as principal counsel for Cross-Appellants Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira, Inc.. Service: 09/13/2018 by email. [549481] [18-2321] [James Hurst] [Entered: 09/13/2018 12:14 PM] (2) |
| Sep 12, 2018 | 7 | Entry of appearance for Eugene M. Gelernter as of counsel for Appellant Janssen Biotech, Inc.. Service: 09/12/2018 by email. [549273] [18-2321] [Eugene Gelernter] [Entered: 09/12/2018 04:27 PM] (2) |
| Sep 12, 2018 | 6 | Certificate of Interest for the Appellant Janssen Biotech, Inc.. Service: 09/12/2018 by email. [549232] [18-2321] [Gregory Diskant] [Entered: 09/12/2018 03:20 PM] (3) |
| Sep 12, 2018 | 5 | Docketing Statement for the Appellant Janssen Biotech, Inc.. Service: 09/12/2018 by email. [549231] [18-2321] [Gregory Diskant] [Entered: 09/12/2018 03:18 PM] (4) |
| Sep 12, 2018 | 4 | Entry of appearance for Gregory L. Diskant as principal counsel for Appellant Janssen Biotech, Inc.. Service: 09/12/2018 by email. [549230] [18-2321] [Gregory Diskant] [Entered: 09/12/2018 03:14 PM] (2) |
| Sep 10, 2018 | 3 | Official caption revised to add cross-appeal 18-2350. The official caption is reflected on the electronic docket under the listing of the parties and counsel. Service as of this date by the Clerk of Court. [548393] [JB] [Entered: 09/10/2018 12:13 PM] (0) |
| Sep 10, 2018 | 2 | Note to file: The following cases are associated:18-2321 (Lead) with 18-2350 (Cross-Appeal). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [548392] [JB] [Entered: 09/10/2018 12:12 PM] (0) |
| Aug 30, 2018 | 1 | Appeal docketed. Received: 08/27/2018. [546516]Entry of Appearance due 09/13/2018. Certificate of Interest is due on 09/13/2018. Docketing Statement due 09/13/2018. Appellant/Petitioner's brief is due 10/29/2018. [JB] [Entered: 08/30/2018 03:48 PM] (170) |
